ZDS-LIOTHYRONINE DIN 02561301
Status: Marketed
Holder: ZYDUS LIFESCIENCES LIMITED
Health Canada record
| Active ingredient(s) | LIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | H03AA02 LIOTHYRONINE SODIUM |
|---|
| Original market date | 15-Jan-2026 |
|---|
| Current status date | 15-Jan-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zydus Lifesciences Limited — licence , not currently licensed, last inspection rating C (2025-06-09).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LIOTHYRONINE (LIOTHYRONINE SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02549999 | AURO-LIOTHYRONINE | AURO PHARMA INC | Tablet | LIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCG | Marketed |
| 02550008 | AURO-LIOTHYRONINE | AURO PHARMA INC | Tablet | LIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCG | Marketed |
| 01919466 | CYTOMEL | PFIZER CANADA ULC | Tablet | LIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCG | Marketed |
| 01919458 | CYTOMEL | PFIZER CANADA ULC | Tablet | LIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCG | Marketed |
| 02494345 | TEVA-LIOTHYRONINE | TEVA CANADA LIMITED | Tablet | LIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCG | Marketed |
| 02494337 | TEVA-LIOTHYRONINE | TEVA CANADA LIMITED | Tablet | LIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCG | Marketed |
| 02561298 | ZDS-LIOTHYRONINE | ZYDUS LIFESCIENCES LIMITED | Tablet | LIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 36099 | 2025-10-03 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for ZDS-LIOTHYRONINE
How to read a Canadian DIN record